...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Hepatology: Official Journal of the American Association for the Study of Liver Diseases >Addressing Social Determinants of Liver Disease During the COVID-19 Pandemic and Beyond: A Call to Action
【24h】

Addressing Social Determinants of Liver Disease During the COVID-19 Pandemic and Beyond: A Call to Action

机译：在Covid-19大流行和超越期间解决肝病的社会决定因素：呼吁采取行动

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

The COVID-19 pandemic has exposed healthcare inequities in the USA and highlighted the importance of social conditions in shaping the health of persons. In the field of hepatology, social determinants of health (SDOH) are closely linked to disparities in liver disease prevalence, outcomes, and access to treatment. The economic disruption and physical distancing policies brought on by the COVID-19 pandemic have further exacerbated these disparities, and may have long-lasting health consequences for marginalized patients with chronic liver disease. There are several ways that hepatology providers can bridge the gap in health equity through addressing SDOH, extending from the individual to the community and societal levels. Interventions at the individual level include implementation of systematic screening for social barriers in our hepatology practices to identify gaps in the care cascade. At the community and societal levels, interventions include creating collaborative partnerships with public health workers to expand healthcare access to the community, increasing funding for research investigating the association of SDOH, health disparities, and liver disease, engaging in advocacy to support policy reform that tackles the upstream social determinants, and addressing racism and implicit bias. As hepatology practices adapt to the "new normal," now is the time for us to address our patients' social needs within the context of healthcare delivery and reimagine ways in which to provide care to best serve our most vulnerable patients with liver disease in the COVID-19 era and beyond.
机译：2019冠状病毒疾病已经暴露了美国的医疗不公平，并强调了社会条件在塑造人的健康方面的重要性。在肝病学领域，健康的社会决定因素（SDOH）与肝病患病率、结果和治疗机会的差异密切相关。2019冠状病毒疾病的经济破坏和物理疏远政策进一步加剧了这些差异，并可能对长期肝病边缘化的患者产生长期的健康后果。有几种方法可以让肝病提供者通过解决SDOH（从个人到社区和社会层面）来弥合卫生公平方面的差距。个人层面的干预措施包括在我们的肝病实践中对社会障碍进行系统筛查，以确定护理级联中的差距。在社区和社会层面，干预措施包括与公共卫生工作者建立合作伙伴关系，以扩大社区的医疗服务，增加对调查SDOH、健康差距和肝病之间关系的研究的资金，参与宣传，支持应对上游社会决定因素的政策改革，以及解决种族主义和隐性偏见问题。随着肝病学实践适应“新常态”，现在是我们在医疗保健交付的背景下解决患者的社会需求的时间，并重新设想在CVID-19时代及以上范围内为我们最易患肝病的患者提供护理服务的方式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号